Alnylam Pharmaceuticals: Q3 Earnings Insights

Alnylam Pharmaceuticals: Q3 Earnings Insights

Alnylam Pharmaceuticals ALNY reported its Q3 earnings results on Thursday, October 27, 2022 at 08:00 AM.

Here's what investors need to know about the announcement.


Alnylam Pharmaceuticals beat estimated earnings by 11.24%, reporting an EPS of $-1.58 versus an estimate of $-1.78.

Revenue was up $76.67 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.41 which was followed by a 1.03% drop in the share price the next day.

Here's a look at Alnylam Pharmaceuticals's past performance:


Quarter Q2 2022 Q1 2022 Q4 2021 Q3 2021
EPS Estimate -1.62 -1.84 -1.54 -1.57
EPS Actual -2.03 -1.49 -1.69 -1.51
Revenue Estimate 255.88M 243.02M 233.62M 218.69M
Revenue Actual 224.82M 213.26M 258.54M 187.63M

To track all earnings releases for Alnylam Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: BZI-RecapsEarnings